SL Science Holding Limited - Ordinary Shares (SLBT)

Taipei, TAIWAN, June 18, 2026 (GLOBE NEWSWIRE) --  SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced its financial results for the full year ended December 31, 2025.